CHST1 | Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CHST6 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CIT | Citron (rho-interacting, serine/threonine kinase 21) | Enzymes
| | | | | Tissue enhanced |
CLCN4 | Chloride channel, voltage-sensitive 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLIP3 | CAP-GLY domain containing linker protein 3 | | | | | | Tissue enhanced |
CNGB1 | Cyclic nucleotide gated channel beta 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNNM1 | Cyclin M1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CNR1 | Cannabinoid receptor 1 (brain) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CNTN1 | Contactin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CNTNAP1 | Contactin associated protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COLGALT2 | Collagen beta(1-O)galactosyltransferase 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CORO2B | Coronin, actin binding protein, 2B | Plasma proteins
| | | | | Tissue enhanced |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPNE4 | Copine IV | | | | | | Tissue enhanced |
CPNE9 | Copine family member IX | | | | | | Tissue enhanced |
CPT1C | Carnitine palmitoyltransferase 1C | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CRB2 | Crumbs homolog 2 (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRHR1 | Corticotropin releasing hormone receptor 1 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CRMP1 | Collapsin response mediator protein 1 | | | | | | Tissue enhanced |
CSRNP3 | Cysteine-serine-rich nuclear protein 3 | Transcription factors
| | | | | Tissue enhanced |
CTD-2207O23.12 | Uncharacterized protein | | | | | | Tissue enhanced |
CTD-3193O13.9 | Protein FLJ22184 | | | | | | Tissue enhanced |
CTXN1 | Cortexin 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CTXN2 | Cortexin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CX3CR1 | Chemokine (C-X3-C motif) receptor 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DAGLA | Diacylglycerol lipase, alpha | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
DBX2 | Developing brain homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DCLK2 | Doublecortin-like kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
DGKB | Diacylglycerol kinase, beta 90kDa | Enzymes Plasma proteins
| | | | | Tissue enhanced |
DISP2 | Dispatched homolog 2 (Drosophila) | Predicted membrane proteins
| | | | | Tissue enhanced |
DLEU7 | Deleted in lymphocytic leukemia, 7 | | | | | | Tissue enhanced |
DLG2 | Discs, large homolog 2 (Drosophila) | | | | | | Tissue enhanced |
DMRTC1 | DMRT-like family C1 | Transcription factors
| | | | | Tissue enhanced |
DMRTC1B | DMRT-like family C1B | Transcription factors
| | | | | Tissue enhanced |
DNAH10OS | Dynein, axonemal, heavy chain 10 opposite strand | | | | | | Tissue enhanced |
DNM3 | Dynamin 3 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
DOCK3 | Dedicator of cytokinesis 3 | Disease related genes
| | | | | Tissue enhanced |
DPP10 | Dipeptidyl-peptidase 10 (non-functional) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DPYSL4 | Dihydropyrimidinase-like 4 | Plasma proteins
| | | | | Tissue enhanced |
DRD1 | Dopamine receptor D1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
DSCAML1 | Down syndrome cell adhesion molecule like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
DTNA | Dystrobrevin, alpha | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DYNC1I1 | Dynein, cytoplasmic 1, intermediate chain 1 | | | | | | Tissue enhanced |
EFNB3 | Ephrin-B3 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
EHD3 | EH-domain containing 3 | Plasma proteins
| | | | | Tissue enhanced |
EIF4E1B | Eukaryotic translation initiation factor 4E family member 1B | | | | | | Tissue enhanced |
EPHB1 | EPH receptor B1 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |